84.4% of cancer patients taking ivermectin + mebendazole declared NO EVIDENCE OF DISEASE, TUMOR SHRINKAGE, or CANCER STABILIZATION after 6 months.
— Nicolas Hulscher, MPH (@NicHulscher) April 15, 2026
HUNDREDS of preclinical studies explain why: anti-parasitics exert over 12 anti-cancer mechanisms across more than 12 cancer types. pic.twitter.com/U288SgLE1f